Repetitive levosimendan in outpatients affected by advanced heart failure: the need for a uniform approach.
暂无分享,去创建一个
[1] R. Gravino,et al. Efficacy and safety of repeated infusion of levosimendan in outpatients with advanced heart failure: a real-world experience , 2020, Journal of cardiovascular medicine.
[2] F. Fedele,et al. Repetitive levosimendan treatment in the management of advanced heart failure , 2018, European heart journal supplements : journal of the European Society of Cardiology.
[3] Davor Milicic,et al. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology , 2018, European journal of heart failure.
[4] F. Fedele,et al. Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy. , 2017, International journal of cardiology.
[5] H. Ulmer,et al. Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial , 2014, European journal of heart failure.